Ujjivan Small Finance Bank Limited (BOM:542904)

Theseus Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-	7,261	12,815	10,999	-4,146	82.97
Depreciation & Amortization	-	1,347	982.9	902.79	804.43	768.01
Gain (Loss) on Sale of Assets	-	4.85	14.72	6.7	19.97	7.69
Gain (Loss) on Sale of Investments	-	443.81	124.4	252.26	184.46	639.28
Provision for Credit Losses	-	7,477	2,149	175.7	11,645	7,990
Change in Other Net Operating Assets	-	-57,679	-65,056	-75,045	-32,698	-4,709
Other Operating Activities	-	-428.99	3,824	760.81	-1,814	-1,988
Operating Cash Flow	-	-41,401	-45,030	-61,857	-26,020	3,014
Capital Expenditures	-	-1,672	-2,457	-1,254	-514.81	-581.39
Sale of Property, Plant and Equipment	-	17.5	21.61	9.2	3.77	3.24
Investment in Securities	-	-16,280	-6,210	-19,713	-7,899	-12,986
Investing Cash Flow	-	-17,934	-8,645	-20,957	-8,410	-13,564
Long-Term Debt Issued	-	6,745	-	8,779	-	-
Total Debt Issued	-	6,745	-	8,779	-	-
Long-Term Debt Repaid	-	-	-4,706	-	-14,838	-7,059
Net Debt Issued (Repaid)	-	6,745	-4,706	8,779	-14,838	-7,059
Issuance of Common Stock	-	137.71	202.64	4,661	-	4.26
Common Dividends Paid	-	-2,901	-683.41	-1,466	-	-
Preferred Dividends Paid	-	-	-	-110	-	-
Total Dividends Paid	-	-2,901	-683.41	-1,576	-	-
Net Increase (Decrease) in Deposit Accounts	-	61,683	60,958	72,455	51,564	23,553
Financing Cash Flow	-	65,666	55,771	84,319	36,727	16,498
Net Cash Flow	-	6,330	2,103	1,505	2,297	5,947
Free Cash Flow	-	-43,073	-47,487	-63,110	-26,535	2,433
Free Cash Flow Margin	-	-115.33%	-119.27%	-193.04%	-280.49%	19.61%
Free Cash Flow Per Share	-	-22.02	-24.22	-34.04	-15.35	1.41
Cash Income Tax Paid	-	2,584	492.93	2,804	214.56	2,090

Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.